Type 1 Diabetes News and Research

Latest Type 1 Diabetes News and Research

Diabetes medication shows promise in cutting migraine days by more than half

A diabetes medication that lowers brain fluid pressure has cut monthly migraine days by more than half, according to a new study presented today at the European Academy of Neurology (EAN) Congress 2025.

20 Jun 2025

New ACC guidance helps incorporate pharmacologic weight management strategies into cardiovascular care

The American College of Cardiology has issued a Concise Clinical Guidance (CCG) document to aid clinicians in the use of medication for weight management in patients where treatment may provide cardiovascular benefit.

20 Jun 2025

New Swedish research initiative targets obesity and metabolic diseases

Metabolism and obesity are the focus of a major research initiative by the University of Gothenburg and AstraZeneca, with the support of Knut and Alice Wallenberg Foundation and Region Västra Götaland.

19 Jun 2025

Aspirin lowers diabetes risk during COVID-19, but not without side effects

A large real-world Italian cohort study found that daily low-dose aspirin use significantly lowered the risk of developing type 2 diabetes, especially during the COVID-19 pandemic. The protective effect appears linked to aspirin’s anti-inflammatory properties, though bleeding risks require caution.

19 Jun 2025

Higher ocean microplastics linked to more diabetes, stroke, and heart disease

A new ecological study links high marine microplastic levels near US coastlines with significantly greater prevalence of type 2 diabetes, coronary artery disease, and stroke. The findings raise concerns about environmental exposure through seafood, groundwater, and air in vulnerable coastal communities.

19 Jun 2025

Rapamycin offers life-extending benefits comparable to eating less

The anti-aging drug Rapamycin has the same life-extending effect as eating less, according to new research from the University of East Anglia and University of Glasgow.

19 Jun 2025

T cells play key role in early stages of Parkinson’s disease

Your T cells work hard to fight disease. Unfortunately, "friendly fire" from T cells can sometimes harm the body's healthy tissues.

19 Jun 2025

C-Path’s TRxA awards $250,000 grant to develop novel treatment for type 1 diabetes

Critical Path Institute's (C-Path) Translational Therapeutics Accelerator (TRxA) proudly announced today a $250,000 grant award aimed at developing a novel treatment for type 1 diabetes (T1D).

19 Jun 2025

Intermittent fasting shows similar weight loss benefits to traditional diets

Intermittent fasting diets appear to have similar benefits to traditional calorie-restricted diets for weight loss, suggests an analysis of trial evidence published by The BMJ today.

19 Jun 2025

How early-life factors raise lifelong diabetes risks in youth

The surge in diabetes among young people highlights critical gaps in care and the urgent need for comprehensive preventative actions to address this crisis.

19 Jun 2025

Can salt substitutes lower blood pressure in diabetes? A new Cochrane review aims to find out

Researchers will systematically review whether replacing regular sodium salt with alternatives like potassium or magnesium salts helps lower blood pressure in adults with diabetes. The protocol outlines a rigorous plan to evaluate blood pressure effects, safety, and adherence using data from RCTs and quasi-RCTs.

18 Jun 2025

Equal access, unequal impact: Parkinson’s hits minorities harder in the UK

Researchers in East London found that South Asian and Black Parkinson’s disease patients experience more severe motor and cognitive symptoms than White patients. Despite similar access to diagnosis, disparities persist, highlighting the need for more inclusive and culturally sensitive care.

18 Jun 2025

Oxytocin stimulates pancreatic hormones to improve insulin secretion

A new research paper was published in Aging (Aging-US) Volume 17, Issue 5, on May 1, 2025, titled "Oxytocin modulates insulin and GLP-1 secretion in pancreatic islets."

18 Jun 2025

Living near microplastic polluted waters linked to higher risk of heart and metabolic diseases

Living in a U.S. coastal county bordered by ocean waters with very high concentrations of microplastics may increase the risk of heart and metabolic diseases, such as Type 2 diabetes, coronary artery disease and stroke.

18 Jun 2025

Nurse practitioners critical in treating older adults as ranks of geriatricians shrink

On Fridays, Stephanie Johnson has a busy schedule, driving her navy-blue Jeep from one patient’s home to the next, seeing eight in all.

18 Jun 2025

What matters more for diabetes risk: lifestyle or body weight?

A large, multi-ethnic US cohort study found that combining healthy lifestyle factors—non-smoking, regular physical activity, a healthy diet, and moderate alcohol consumption into a Lifestyle Risk Factor Index (LSRI) was linked to a significantly lower risk of type 2 diabetes. However, BMI was a stronger predictor of diabetes risk, and the impact of lifestyle varied across ethnic groups.

18 Jun 2025

Combination therapy may improve health outcomes in adolescents with type 1 diabetes

A clinical trial involving adolescents with type 1 diabetes (T1D) has found a combination therapy may reduce chronic kidney disease and improve health outcomes.

17 Jun 2025

What 300 grams of ultra-processed food a day does to your diabetes risk

A dose-response meta-analysis of 12 cohort studies finds that higher intake of ultra-processed foods (UPFs) is linked to a significantly increased risk of type 2 diabetes (T2D). The association remains even after adjusting for BMI, diet quality, and energy intake, with a steeper risk increase above 300 g/day.

17 Jun 2025

Muscle ultrasound shows promise for early insulin resistance detection

A simple ultrasound of a patient's thigh or shoulder muscle may detect insulin resistance before it progresses to type 2 diabetes or even prediabetes.

17 Jun 2025

Bariatric surgery leads to greater weight loss than GLP-1 drugs after two years

Sleeve gastrectomy and gastric bypass were associated with about five-times more weight loss than weekly injections of GLP-1 receptor agonists semaglutide or tirzepatide, at the end of two years, according to a new head-to-head real-world study presented today at the American Society for Metabolic and Bariatric Surgery (ASMBS) 2025 Annual Scientific Meeting.

17 Jun 2025

Type 1 Diabetes News and Research

Latest Type 1 Diabetes News and Research

Diabetes medication shows promise in cutting migraine days by more than half

New ACC guidance helps incorporate pharmacologic weight management strategies into cardiovascular care

New Swedish research initiative targets obesity and metabolic diseases

Aspirin lowers diabetes risk during COVID-19, but not without side effects

Higher ocean microplastics linked to more diabetes, stroke, and heart disease

Rapamycin offers life-extending benefits comparable to eating less

T cells play key role in early stages of Parkinson’s disease

C-Path’s TRxA awards $250,000 grant to develop novel treatment for type 1 diabetes

Intermittent fasting shows similar weight loss benefits to traditional diets

How early-life factors raise lifelong diabetes risks in youth

Can salt substitutes lower blood pressure in diabetes? A new Cochrane review aims to find out

Equal access, unequal impact: Parkinson’s hits minorities harder in the UK

Oxytocin stimulates pancreatic hormones to improve insulin secretion

Living near microplastic polluted waters linked to higher risk of heart and metabolic diseases

Nurse practitioners critical in treating older adults as ranks of geriatricians shrink

What matters more for diabetes risk: lifestyle or body weight?

Combination therapy may improve health outcomes in adolescents with type 1 diabetes

What 300 grams of ultra-processed food a day does to your diabetes risk

Muscle ultrasound shows promise for early insulin resistance detection

Bariatric surgery leads to greater weight loss than GLP-1 drugs after two years

Industry Focus eBook - Medical device (1st edition) eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Type 1 Diabetes News and Research

Latest Type 1 Diabetes News and Research

Industry Focus eBook - Medical device (1st edition) eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Newsletters you may be interested in